• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Infectious Disease

Decrease in foreign-born tuberculosis linked to culture-based screening

byNicholas WoolfandSai Folmsbee
March 17, 2015
in Infectious Disease, Public Health
Reading Time: 2 mins read
Shorter moxifloxacin-containing regimens ineffective for treating TB [REMoxTB trial]
Share on FacebookShare on Twitter

1. From a cross-sectional study, the implementation of a new culture-based tuberculosis (TB) screening algorithm for immigrants was associated with a reduction in the annual number of TB cases.

2. The number of smear-negative/culture-positive TB cases successfully diagnosed abroad increased from 4 to 629 during the same period.

Evidence Rating Level: 2 (Good)

Study Rundown: Immigrants account for the majority of new tuberculosis (TB) cases diagnosed annually in the United States. To combat this, U.S. immigrants must pass a TB screening protocol, which before 2007 included a chest X-ray and a smear-based algorithm. However, because cases of TB remained undetected, the CDC added a culture-based screening algorithm. This study examined the effect of the culture-based algorithm on new TB diagnoses in the U.S. and abroad from 2007 to 2012. Before implementation of the culture-based algorithm, the average number of new TB cases diagnosed annually in the U.S. was 1504. During implementation, the number of new cases dropped to 940 in 2012, while the number of smear-negative/culture-positive cases diagnosed abroad increased during the same time period. The total number of smear-negative/culture-positive cases diagnosed from 2007 to 2012 was 2195. The study is limited in that it did not control for the decline in the amount of non-immigrant visitors to U.S. and the decline in TB incidence in their countries of origin. Overall, the new protocol was associated with the import of fewer cases of TB into the U.S.

Click to read the study, published today in the Annals of Internal Medicine

Relevant Reading: Overseas screening for tuberculosis in U.S.-bound immigrants and refugees

RELATED REPORTS

Near-point-of-care molecular test accurately detects pulmonary tuberculosis

Poor baseline lung function associated with increased risk of incident tuberculosis

Artificial intelligence demonstrates non-inferiority to radiologists at tuberculosis detection within a population with a high-disease burden

In-Depth [cross-sectional study]: The study examined TB screening records of 3 212 421 immigrants and refugees who arrived in the U.S. between 2007 and 2012. Of this population, 1 650 961 (51.4%) were screened by the smear-based algorithm and 1 561 460 (48.6%) were screened by the culture-based algorithm. Among the people screened by the culture-based algorithm, 4032 were diagnosed with TB, and 2195 of these cases were smear-negative/culture-positive. The number of U.S. immigrant TB cases dropped from 1511 in 2007 to 940 in 2012, which coincided with a 157-fold increase in smear-negative/culture-positive TB diagnoses made overseas during the same period (4 in 2007 vs. 629 in 2012).

Image: PD

©2015 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: tuberculosis
Previous Post

Improved hepatitis C drugs may increase healthcare costs

Next Post

Agreement between pathologists on interpretation of breast biopsies about 75%

RelatedReports

Shorter moxifloxacin-containing regimens ineffective for treating TB [REMoxTB trial]
Infectious Disease

Near-point-of-care molecular test accurately detects pulmonary tuberculosis

May 4, 2026
Lessons from real-world implementation of lung cancer screening
Chronic Disease

Poor baseline lung function associated with increased risk of incident tuberculosis

May 9, 2025
Significant number of wrong-patient errors in radiology reports
2 Minute Medicine

Artificial intelligence demonstrates non-inferiority to radiologists at tuberculosis detection within a population with a high-disease burden

April 10, 2025
Quick Take: Discovery and validation of a prognostic proteomic signature for tuberculosis progression
Infectious Disease

Levofloxacin shows limited efficacy in preventing multidrug-resistant tuberculosis

March 5, 2025
Next Post
Adjuvant radiotherapy reduces recurrence of ductal carcinoma; no effect on long-term prognosis

Agreement between pathologists on interpretation of breast biopsies about 75%

Racial differences in colorectal cancer survival linked to health at initial diagnosis

NSAID use effect on colorectal cancer risk influenced by genetics

Modeling study reveals significant between-country disparities in tobacco use

Modeling study reveals significant between-country disparities in tobacco use

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

5-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Borderline-low hemoglobin levels linked to increased mortality
  • 2MM: Pharma Roundup – mRNA flu vaccine debuts, RAS inhibition extends pancreatic cancer survival, and new therapies advance for dermatomyositis and Tourette syndrome
  • 2 Minute Medicine Rewind September 14, 2026
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

5-day free trial · cancel anytime

Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free · only $4.16/month

Start 5-day free trial

Then $49.90/year. Manage renewal in your account.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.